Načítá se...
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease
Pulmonary hypertension affects ∼10% of adult patients with sickle cell disease (SCD), particularly those with the homozygous genotype. An increase in pulmonary artery systolic pressure, estimated noninvasively by echocardiography, helps identify SCD patients at risk for pulmonary hypertension, but d...
Uloženo v:
| Vydáno v: | Blood |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4760088/ https://ncbi.nlm.nih.gov/pubmed/26758918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-08-618561 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|